32.41

14.89% 4.20

After Hours: 31.85 -0.56 -1.73%

Roivant Sciences Ltd (ROIV)

Overview News Price History Option Chain Financials Why ROIV Down? Discussions Forecast

Roivant Sciences Ltd stock is traded at $32.41, with a volume of 17.00M. It is up +14.89% in the last 24 hours and up +11.45% over the past month. Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Previous Close:

$28.21

Open:

$29.6

24h Volume:

17.00M

Relative Volume:

3.01

Market Cap:

$23.20B

Revenue:

$13.31M

Net Income/Loss:

$-1.01B

P/E Ratio:

-27.74

EPS:

-1.1685

Net Cash Flow:

$-766.86M

1W Performance:

+10.92%

1M Performance:

+11.45%

6M Performance:

+59.89%

1Y Performance:

+193.57%

1-Day Range:

$29.35

$32.79

1-Week Range:

$27.85

$32.79

52-Week Range:

$10.59

$32.79

Roivant Sciences Ltd Stock (ROIV) Company Profile

Name

Roivant Sciences Ltd

Sector

Healthcare (1099)

Industry

Biotechnology (615)

Phone

441-295-5950

Address

7TH FLOOR, 50 BROADWAY, LONDON

Employee

750

Twitter

Next Earnings Date

2026-05-20

Latest SEC Filings

ROIV's Discussions on Twitter

Compare ROIV vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ROIV Roivant Sciences Ltd	32.41	20.43B	13.31M	-1.01B	-766.86M	-1.1685
VRTX Vertex Pharmaceuticals Inc	430.44	110.81B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.76	66.02B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	804.25	48.27B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.48	38.22B	4.29B	577.22M	641.34M	4.2086
ONC Beone Medicines Ltd Adr	308.74	30.41B	5.76B	514.49M	1.10B	4.4813

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-20-26	Initiated	Bernstein	Outperform
Sep-02-25	Initiated	Citigroup	Buy
Jul-10-25	Resumed	Goldman	Buy
Feb-15-24	Initiated	Wolfe Research	Outperform
Jan-05-24	Initiated	Piper Sandler	Overweight
Dec-12-23	Initiated	Deutsche Bank	Buy
Oct-17-23	Initiated	Guggenheim	Buy
Jun-08-23	Initiated	BofA Securities	Neutral
Oct-27-22	Initiated	JP Morgan	Overweight
May-23-22	Initiated	SVB Leerink	Outperform
Apr-29-22	Initiated	Cantor Fitzgerald	Overweight
Dec-15-21	Initiated	Goldman	Buy
Nov-08-21	Initiated	H.C. Wainwright	Buy
Oct-28-21	Initiated	Citigroup	Buy
Oct-26-21	Initiated	Cowen	Outperform
Oct-26-21	Initiated	Jefferies	Buy
Oct-26-21	Initiated	Truist	Buy

View All

Roivant Sciences Ltd Stock (ROIV) Latest News

01:44 AM

Roivant Sciences stock hits all-time high of 30.35 USD By Investing.com - Investing.com Canada

01:44 AM

12:45 PM

Roivant Sciences earnings beat by $0.57, revenue fell short of estimates - Investing.com India

12:45 PM

12:30 PM

Why is Roivant Sciences stock surging today? By Investing.com - Investing.com South Africa

12:30 PM

12:07 PM

ROIV: High efficacy in refractory RA, strong cash, and major launches expected in the coming year - TradingView

12:07 PM

11:26 AM

Roivant Sciences (ROIV) Surges 14.8% to $32.38 - AlphaStreet

11:26 AM

10:55 AM

Roivant Sciences Shares Jump 14.43% to $32.28 on Strong IMVT-1402 Rheumatoid Arthritis Data - International Business Times Australia

10:55 AM

10:36 AM

Roivant Sciences Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2026 - marketscreener.com

10:36 AM

10:10 AM

Roivant gains after mid-stage trial data for Immunovant’s main asset - Seeking Alpha

10:10 AM

10:07 AM

Roivant Sciences Q4 Earnings Call Highlights - inkl

10:07 AM

Immunovant Q4 Earnings Call Highlights - inkl

10:07 AM

10:02 AM

TAT Technologies Posts Upbeat Q1 Earnings, Joins Roivant Sciences, Immunitybio And Other Big Stocks Movin - Benzinga

10:02 AM

09:36 AM

Roivant Sciences stock hits all-time high of 30.35 USD - Investing.com

09:36 AM

09:31 AM

Roivant Sciences Ltd reports results for the quarter ended March 31Earnings Summary - TradingView

09:31 AM

09:28 AM

Earnings call transcript: Roivant Sciences surprises with Q4 2026 EPS beat - Investing.com Canada

09:28 AM

Roivant Sciences Reports Q4 2026 Results: Full Earnings Call Transcript - Benzinga

09:28 AM

08:45 AM

Roivant Shares Climb on Earnings Beat Despite Revenue Shortfall (ROIV) - Yahoo Finance

08:45 AM

08:19 AM

Roivant Sciences : Financial Results and Business Updates for the Year Ended March 31 2026 - marketscreener.com

08:19 AM

08:15 AM